Recent RCUS News
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 09/24/2024 08:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 10:42:08 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 09/10/2024 08:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:12:21 PM
- Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital • Business Wire • 08/27/2024 08:05:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 08/26/2024 08:35:00 PM
- Arcus Biosciences to Participate in Two Upcoming Investor Conferences • Business Wire • 08/21/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 08:45:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:15:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:09:14 PM
- Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update • Business Wire • 08/08/2024 08:05:00 PM
- Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update • Business Wire • 07/25/2024 08:05:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 07/09/2024 08:35:00 PM
- Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia • Business Wire • 07/08/2024 10:00:00 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 06/25/2024 08:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:53:54 PM
- Arcus Biosciences Announces New Employment Inducement Grants • Business Wire • 06/11/2024 08:35:00 PM
- Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers • Business Wire • 06/10/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 10:20:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 10:20:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 10:19:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:28:54 PM
- Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/06/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:18:10 PM
- Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer • Business Wire • 06/02/2024 12:00:00 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM